Coagulation aberrations in adult patients with acute leukemia: A single center experience

Sarah Alnuaimy

doi:10.15218/zjms.2024.14

Authors

Sarah Alnuaimy Unit of Hematopathology, Nanakali Hemato-Oncology Hospital, Erbil, Iraq.

DOI:

https://doi.org/10.15218/zjms.2024.14

Keywords:

Acute leukemia, bleeding, Hemostatic derangement

Abstract

Background and objective: Acute leukemia (AL) patients are at high risk for bleeding and thrombotic events due to the disruption of the normal hemostatic system associated with this disease. As a result of the lack of data on coagulopathy in AL patients in our locality, we conducted this study to assess the hemostatic parameters in patients with newly diagnosed AL at the time of presentation.

Methods: This prospective cross-sectional study included 59 patients with de novo AL, along with 35healthy control subjects. The study was conducted at Nanakali Hemato-Oncology Center between September 2021 and May 2022. Coagulation markers, including prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen levels (FBG), D-dimer (D-Di), antithrombin (AT), protein C (PC), and protein S (PS) were measured for each patient and control.

Results: The median age of the patients was 41 years, with a male to female ratio of 1.1:1. Thirty-eight (64.4%) patients had acute myeloid leukemia (AML) and 21 (35.6%) patients had acute lymphoblastic leukemia (ALL). D-Dilevels were significantly raised in both AML and ALL compared to controls. PT was significantly higher, and PC and AT were significantly lower in AML compared to ALL or control groups. The Bleeding incidence in AML was significantly higher than in ALL (65.8% versus 23.8%). Thrombosis occurred in two (3.4%) patients.

Conclusion: Coagulation abnormalities were common in AL. The hemostatic derangement and bleeding at the time of presentation were more pronounced in patients with AML than in ALL.

Metrics

Metrics Loading ...

References

Okikiolu J, Dillon R, Raj K. Acute leukaemia. Medicine 2021; 49(5):274–81.https://doi.org/10.1016/j.mpmed.2021.02.004.

Rose-Inman H, Kuehl D. Acute leukemia. Hematol Oncol Clin North Am 2017; 31(6):1011–28. https://doi.org/10.1016/j.hoc.2017.08.006.

Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y, et al.Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol 2020;9(1):14. https://doi.org/10.1186/s40164-020-00170-6.

Cate HT, Leader A.Management of disseminated intravascular coagulation in acute leukemias. Hamostaseologie 2021; 41(2):120–6. https://doi.org/10.1055/a-1393-8302.

Kwaan HC, Weiss I, Tallman MS. The role of abnormal hemostasis and fibrinolysis in morbidity and mortality of acute promyelocytic leukemia. Semin Thromb Hemost 2019; 45(06):612–21. https://doi.org/10.1055/s-0039-1693478.

Lad D, Jain A, Varma S. Complications and management of coagulation disorders in leukemia patients. Blood Lymphat Cancer 2017; 7:61–72.https://doi.org/10.2147/BLCTT.S125121.

Ismail MM, Hamed GM. Activity levels of natural anticoagulant proteins in childhood acute lymphoblastic leukemia: relation to thromboembolic complications and treatment. Blood Coagul Fibrinolysis 2017; 28(1):1–7. https://doi.org/10.1097/MBC.0000000000000521.

Chu T, Wang H, Lv X, Qi J, Tang Y, Fan Y, et al. Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia. Platelets 2021; 32(5):677–83. https://doi.org/10.1080/09537104.2020.1799969.

Tawfiq S, Yassin A, AlGetta H, Hassan K. Acute myeloblastic leukemia: important clinical and epidemiological facts from Hiwahospital in Sulaimaniyah, Iraq. Iraqi Journal of Hematology 2019; 8:69. https://doi.org/10.4103/ijh.ijh_11_19.

Abuhelwa Z, Shaer QA, Taha S, Ayoub K, Amer R. Characteristics of de novo acute myeloid leukemia patients in Palestine: experience of An-Najah national university hospital. Asian Pac J Cancer Prev 2017; 18(9):2459–64. https://doi.org/10.22034/APJCP.2017.18.9.2459.

Karim ZA, Khidhir KG, Ahmed RA, Hassan HA, Karim DO. Leukemia study in Sulaymaniyah province, Kurdistan, Iraq. Chin Med J (Engl) 2016; 129(2):244–5. https://doi.org/10.4103%2F0366-6999.173551.

Gómez-Almaguer D, Marcos-Ramírez ER, Montaño-Figueroa EH, Ruiz-Argüelles GJ, Best-Aguilera CR, López-Sánchez MDC, et al. Acute leukemia characteristics are different around the world: the Mexican perspective. Clin Lymphoma Myeloma Leuk 2017; 17(1):46–51. https://doi.org/10.1016/j.clml.2016.09.003.

Favaloro EJ. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost 2010; 36(4):458–67. https://doi.org/10.1055/s-0030-1254055.

Hu W, Wang X, Yang R. Evaluation of D-dimer and lactate dehydrogenaseplasma levels in patients with relapsed acute leukemia. Oncol Lett 2016;12(1):591–6. https://doi.org/10.3892/ol.2016.4657.

Chowdhury MU, Begum M, Khan MR, Kabir AL, Islam S, Layla KN, et al. Disseminated intravascular coagulation at diagnosis in acute myeloblastic leukaemia. J Biosci Med 2021; 9(10):124–34. https://doi.org/10.4236/jbm.2021.910011.

Choudhry A, DeLoughery TG. Bleeding and thrombosis in acute promyelocytic leukemia. Am J Hematol 2012; 87(6):596–603. https://doi.org/10.1002/ajh.23158.

Franchini M, Di Minno MND, Coppola A. Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost 2010; 36(4):388–403. https://doi.org/10.1055/s-0032-1331154.

Lee HJ, Park HJ, Kim HW, Park SG. Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation. Blood Res 2013; 48(4):250–3. https://doi.org/10.5045/br.2013.48.4.250.

Shahab F, Raziq F. Clinical presentations of acute leukemia. J Coll Physicians Surg Pak 2014; 24(7):472–6.

Cvetković M, Mitrović M. Disseminated intravascular coagulopathy in non-promyelocytic acute myeloid leukemia: incidence, clinical and laboratory features and prognostic significance. Serbian Journal of the Medical Chamber 2021; 2(2):99–109. http://dx.doi.org/10.5937/smclk2-32467.

Shalal HH, Mahmood NS, Alchalabi MAQ. Clinical, hematological, and laboratory presentation of acute lymphoblastic leukemia of children in Diyala province/Eastern Iraq. Int J Res Med Sc 2017; 5(10):4227–33. https://doi.org/10.18203/2320-6012.ijrms20174551.

Libourel EJ, Klerk CPW, van Norden Y, de Maat MPM, Kruip MJ, Sonneveld P, et al. Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia. Blood 2016; 128(14):1854–61. https://doi.org/10.1182/blood-2016-02-701094.

Zhu HH, Ma YF, Yu K, Ouyang GF, Luo WD, Pei RZ, et al. Early death and survival of patients with acute promyelocytic leukemiain ATRA plus arsenic era: a population-based study. Front Oncol 2021; 11. https://doi.org/10.3389/fonc.2021.762653.